pralsetinib - CISMeF

Preferred Label : pralsetinib;

MeSH Hyperonym : Cyclohexanecarboxamide, N-((1S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)-, trans-;

Details

Origin ID

C000655704;

UMLS CUI

C5226874;

Currated CISMeF NLP mapping
- Pralsetinib [NCIt concept]
- Pralsetinib [SMS substance]
- Pralsetinib (substance) [SNOMED CT concept]
MeSH term(s) associated for indexing
- pyrazoles [MeSH Descriptor]
- pyridines [MeSH Descriptor]
- pyrimidines [MeSH Descriptor]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
Record concept(s)
- BLU-667 [MeSH concept]
- gavreto [MeSH concept]
- pralsetinib [MeSH concept]
- trans-N-((1S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)cyclohexanecarboxamide [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Pralsetinib [NCIt concept]
- Pralsetinib (substance) [SNOMED CT concept]
- Product containing pralsetinib (medicinal product) [SNOMED CT concept]
- pralsetinib [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients